Transformation of hepatits B serologic markers in babies born to hepatitis B surface antigen positive mothers

World Journal of Gastroenterology

Volumn 11, Issue 23, 2005, Pages 3582-3585

  Wang, Jian She ^a   Chen, Hui ^a   Zhu, Qi Rong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Children; Chronic; Hepatitis B; Hepatitis B e antibody; Hepatitis B e antigen; Hepatitis B surface antigen; Maternal infantile transmission

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA; BIOLOGICAL MARKER; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; INCIDENCE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PLACENTAL TRANSFER; PRESCHOOL CHILD; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIRUS CARRIER; VIRUS TRANSMISSION; BLOOD; DISEASE TRANSMISSION; PREGNANCY; PREGNANCY COMPLICATION; VIROLOGY;

ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD;

EID: 21344445943     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i23.3582     Document Type: Article

References (20)

1. Malik AH, Lee WM. Hepatitis B therapy: the plot thickens. Hepatology 1999; 30: 579-581
2. Chen CH, Chen YY, Chen GH, Yang SS, Tang HS, Lin HH, Lin DY, Lo SK, Du JM, Chang TT, Chen SC, Liao LY, Kuo CH, Lin KC, Tai DI, Changchien CS, Chang WY, Sheu JC, Chen DS, Liaw YF, Sung JL. Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13676 relatives with hepatocellular carcinoma. J Hepatol 2004; 40: 653-659
3. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 2003; 38: 1075-1086
4. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-26
5. Xu ZY, Duan SC, Margolis HS, Purcell RH, Ou-Yang PY, Coleman PJ, Zhuang YL, Xu HF, Qian SG, Zhu QR. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B. J Infect Dis 1995; 171: 54-60
6. Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003; 57: 100-102
7. Chen H, Zhu QR. Explanation of hepatitis B virus markers after hepatitis B vaccines Inoculation. Zhonghua Ganzangbing Zazhi 2003; 11: 240
8. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990; 87: 6599-6603
9. Wang JS, Zhu QR. Infection of the fetus with hepatitis B e antigen via the placenta. Lancet 2000; 355: 989
10. Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003; 71: 360-366
11. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates. J Viral Hepat 1999; 6: 135-139
12. Ding X, Mizokami M, Yao G, Xu B, Orito E, Ueda R, Nakanishi M. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 2001; 44: 43-47
13. Boxall EH, Sira J, Standish RA, Davies P, Sleight E, Dhillon AP, Scheuer PJ, Kelly DA. Natural history of hepatitis B in perinatally infected carriers. Arch Dis Child Fetal Neonatal Ed 2004; 89: F456-460
14. Chang MH. Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization. Liver Int 2003; 23: 309-314
15. Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, Liang DC, Hsu HM, Chen HL, Hsu HY, Chen DS. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000; 284: 3040-3042
16. Zhu Q, Yu G, Yu H, Lu Q, Gu X, Dong Z, Zhang X. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J 2003; 116: 685-687
17. Merkle H, Deutschle T, Gastrock-Balitsch I, Nusser P, Knehr S, Reifenberg K. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Virology 2000; 273: 149-159
18. Reifenberg K, Deutschle T, Wild J, Hanano R, Gastrock-Balitsch I, Schirmbeck R, Schlicht HJ. The hepatitis B virus e antigen cannot pass the murine placenta efficiently and does not induce CTL immune tolerance in H-2b mice in utero. Virology 1998; 243: 45-53
19. Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci USA 2004; 101: 14913-14918
20. Chang MH, Hsu HY, Huang LM, Lee PI, Lin HH, Lee CY. The role of transplacental hepatitis B core antibody in the mother-to-infant transmission of hepatitis B virus. J Hepatol 1996; 24: 674-679